Whole-blood viscosity increases significantly in small arteries and capillaries in hemodiafiltration. Does acute hemorheological change trigger cardiovascular risk events in hemodialysis patient?

Hemodialysis International

Volumn 14, Issue 4, 2010, Pages 433-440

  Canaud, Bernard ^a,b   Rodriguez, Annie ^b   Chenine, Leila ^a   Morena, Marion ^b   Jaussent, Isabelle ^c,d   Leray Moragues, Hélène ^a,b   Picard, Annie ^a,b   Cristol, Jean Paul ^a  

^a LAPEYRONIE HOSPITAL   (France)

^b Renal Research and Training Institute   (France)

^c INSERM   (France)

^d UNIV MONTPELLIER   (France)

Author keywords

Cardiovascular risk factor; Chronic kidney disease patients; Dynamic whole blood viscosity; Hemodiafiltration; Hemodialysis

Indexed keywords

HEMOGLOBIN;

ADULT; AGED; ARTERY; ARTERY DIAMETER; ARTICLE; BLOOD RHEOLOGY; BLOOD VISCOSITY; CAPILLARY; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CROSS-SECTIONAL STUDY; FEMALE; HEMODIAFILTRATION; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HYPOXEMIA; MALE; PROTEIN BLOOD LEVEL; SHEAR RATE; VASCULARIZATION; WHOLE BLOOD VISCOSITY;

ADULT; AGED; AGED, 80 AND OVER; ARTERIES; BLOOD VISCOSITY; CAPILLARIES; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; HEMODIAFILTRATION; HEMORHEOLOGY; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS; RISK FACTORS;

EID: 77958518613     PISSN: 14927535     EISSN: 15424758     Source Type: Journal    
DOI: 10.1111/j.1542-4758.2010.00496.x     Document Type: Article

References (43)

1. Silber HA, Bluemke DA, Ouyang P, Du VP, Post WS, Lima JA. The relationship between vascular wall shear stress and flow-mediated dilation: Endothelial function assessed by phase-contrast magnetic resonance angiography. J Am Coil Cardiol. 2001; 38:1859-1865.
2. Tsai AG, Acero C, Nance PR, et al. Elevated plasma viscosity in extreme hemodilution increases perivascular nitric oxide concentration and microvascular perfusion. Am J Physiol Heart Circ Physiol. 2005; 288:H1730-H1739.
3. Lee AJ, Mowbray PV, Lowe GD, Rumley A, Fowkes FG, Allan PL. Blood viscosity and elevated carotid intima-media thickness in men and women: The Edinburgh Artery Study. Circulation. 1998; 97:1467-1473.
4. Tzoulaki I, Murray GD, Lee AJ, Rumley A, Lowe GD, Fowkes FG. Relative value of inflammatory, hemostatic, and rheological factors for incident myocardial infarction and stroke: The Edinburgh Artery Study. Circulation. 2007; 115:2119-2127.
5. Felker GM, Adams KF, Gattis WA, O'Connor CM. Anemia as a risk factor and therapeutic target in heart failure. J Am Coil Cardiol. 2004; 44:959-966.
6. Besarab A, Bolton WK, Browne JK, et al. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med. 1998; 339:584-590.
7. Drueke TB, Locatelli F, CREATE Investigators et al. Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med. 2006; 355:2071-2084.
8. Singh AK, Szczech L; CHOIR Investigators et al. Correction of anemia with epoetin alpha in chronic kidney disease. N Engl J Med. 2006; 355:2085-2098.
9. Pfeffer MA, Burdmann EA; TREAT Investigators. et al. A trial of darbepoetin alpha in type 2 diabetes and chronic kidney disease. N Engl J Med. 2009; 361:2019-2032.
10. Furuland H, Linde T, Sandhagen B, Andren B, Wikstrom B, Danielson BG. Hemorheological and hemodynamic changes in predialysis patients after normalization of hemoglobin with epoetin-alpha. Scand J Urol Nephrol. 2005; 39:399-404.
11. Metry G, Wikstrom B, Valind S, et al. Effect of normalization of hematocrit on brain circulation and metabolism in hemodialysis patients. J Am Soc Nephrol. 1999; 10:854-863.
12. Collins AJ. Influence of target hemoglobin in dialysis patients on morbidity and mortality. Kidney Int Suppl. 2002; 61:44-48.
13. Cheng TO. High hematocrit value is a risk factor for myocardial infarction. J Thorac Cardiovasc Surg. 1999; 117:199-200.
14. Kato S, Amano H, Ito V, et al. Effect of erythropoietin on angiogenesis with the increased adhesion of platelets to the microvessels in the hind-limb ischemia model in mice. J Pharmacal Sci. 2010; 112:167-175.
15. Perl J, Chan CT. Timing of sudden death relative to the hemodialysis procedure. Nat Clin Pract Nephrol. 2006; 2:668-669.
16. Canaud B, Chenine L, Henriet D, Leray H. Online hemodiafiltration: A multipurpose therapy for improving quality of renal replacement therapy. Contrib Nephrol. 2008; 161:191-198.
17. Canaud B. Online hemodiafiltration. Technical options and best clinical practices. Contrib Nephrol. 2007; 158:110-122.
18. Alexy T, Wenby RB, Pais E, Goldstein LJ, Hogenauer W, Meiselman HJ. An automated tube-type blood viscometer: Validation studies. Biorheology. 2005; 42:237-247.
19. Canaud B, Donadieu P, Polito C, et al. Erythropoietin associated hypertension: What role for blood viscosity changes? Nephron. 1989; 51:430-431.
20. Koppensteiner R, Stockenhuber F, Jahn C, Balcke P, Minar E, Ehringer H. Changes in determinants of blood rheology during treatment with haemodialysis and recombinant human erythropoietin. BMJ. 1990; 300:1626-1627.
21. Paulitschke M, Ludat K, Riedel E, Hampl H. Long-term effects of rhEPO therapy on erythrocyte rheology in dialysis patients with different target hematocrits. Clin Nephrol. 2000; 53 (Suppl.):S36-S41.
22. Brimble KS, McFarlane A, Winegard N, Crowther M, Churchill DN. Effect of chronic kidney disease on red blood cell rheology. Clin Hemorheol Microcirc. 2006; 34:411-420.
23. Zydney AL, Oliver JD, Colton CK. A constitutive equation for the viscosity of stored red cell suspensions: Effects of hematocrit, shear rate, and suspending phase. J Rheol. 1991; 35:1639-1680.
24. Vaisman S, Kensey K, Cho YI. Effect of hemodialysis on whole blood viscosity. Int J Artif Organs. 2009; 32:329-335.
25. Vaisman S, Kensey K, Cho YI. Effect of hemodialysis on whole blood viscosity. Int J Artif Organs. 2009; 32:329-335.
26. Burch GE, DePasquale NP. Hematocrit, viscosity and coronary blood flow. Dis Chest. 1965; 48:225-232.
27. Martinez M, Vaya A, Alvarifio J, et al. Hemorheological alterations in patients with chronic renal failure. Effect of hemodialysis. Clin Hemorheol Microcirc. 1999; 21:1-6.
28. Hasler CR, Owen GR, Brunner W. Reinhart WHo Echinocytosis induced by haemodialysis. Nephrol Dial Transplant. 1998; 13:3132-3137.
29. Chatzizisis YS, Coskun AU, Jonas M, Edelman ER, Feldman CL, Stone PH. Role of endothelial shear stress in the natural history of coronary atherosclerosis and vascular remodeling: Molecular, cellular, and vascular behavior. J Am Coil Cardiol. 2007; 49:2379-2393.
30. Boulanger CM, Amabile N, Guerin AP, et al. In vivo shear stress determines circulating levels of endothelial microparticles in end-stage renal disease. Hypertension. 2007; 49:902-908.
31. Rajagopalan S, Dellegrottaglie S, Furniss AL, et al. Peripheral arterial disease in patients with end-stage renal disease: Observations from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Circulation. 2006; 114:1914-1922.
32. Karnik JA, Young BS, Lew NL, et al. Cardiac arrest and sudden death in dialysis units. Kidney Int. 2001; 60:350-357.
33. Bleyer AJ, Hartman J, Brannon PC, Reeves-Daniel A, Satko SG, Russell G. Characteristics of sudden death in hemodialysis patients. Kidney Int. 2006; 69:2268-2273.
34. Ostermann M. Cardiac arrests in hemodialysis patients: An ongoing challenge. Kidney Int. 2008; 73:907-908.
35. Saran R, Bragg-Gresham JL, Levin NW, et al. Longer treatment time and slower ultrafiltration in hemodialysis: Associations with reduced mortality in the DOPPS. Kidney Int. 2006; 69:1222-1228.
36. Movilli E, Gaggia P, Zubani R, et al. Association between high ultrafiltration rates and mortality in uraemic patients on regular haemodialysis. A 5-year prospective observational multicentre study. Nephrol Dial Transplant. 2007; 22:3547-3552.
37. Androne AS, Katz SD, Lund L, et al. Hemodilution is common in patients with advanced heart failure. Circulation. 2003; 107:226-229.
38. Fathallah-Shaykh SA, Brooks ER, Langman CB, Kensey KR. Sodium modeling attenuates rises in whole-blood viscosity during chronic hemodialysis in children with large inter-dialytic weight gain. Pediatr Nephrol. 2006; 21:1179-1184.
39. Movilli E, Camerini C, Viola BF, Bossini N, Strada A, Maiorca R. Blood volume changes during three different profiles of dialysate sodium variation with similar intradialytic sodium balances in chronic hemodialyzed patients. Am J Kidney Dis. 1997; 30:58-63.
40. Jeong SK, Cho YI, Duey M, Rosenson RS. Cardiovascular risks of anemia correction with erythrocyte stimulating agents: Should blood viscosity be monitored for risk assessment? Cardiovasc Drugs Ther. 2010; 24:151-160.
41. Kobayashi S, Okamoto K, Maesato K, Moriya H, Ohtake T. Important role of blood rheology in atherosclerosis of patients with hemodialysis. Hemodiallant. 2005; 9:268-274.
42. Wang S, Boss AH, Kensey KR, Rosenson RS. Variations of whole blood viscosity using Rheolog-a new scanning capillary viscometer. Clin Chim Acta. 2003; 332:79-82.
43. Pop GAM, Hop WJ, Moraru L, et al. Blood electrical impedance closely matches whole blood viscosity as parameter of hemorheology and inflammation. Appl. Rheol. 2003; 13:305-312.